COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...

PR NewswireMay 16 07:00 ET

CollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its Business

Yahoo FinanceApr 23 06:06 ET

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 8 09:06 ET

CollPlant Biotechnologies Ltd (CLGN) Q4 2023 Earnings Call Transcript Highlights: A Year of ...

Yahoo FinanceApr 5 17:45 ET

Buy Rating Affirmed for Collplant Holdings on Strong Financials and Promising Product Pipeline Advancements

TipRanksApr 5 06:25 ET

Earnings Call Summary | Collplant(CLGN.US) Q4 2023 Earnings Conference

The following is a summary of the CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript:Financial Performance:CollPlant reported Q4 2023 revenues of $299,000, an increase from $58,000

moomoo AIApr 4 13:29 ET · Conference Call